Детская хирургия том 1 - Ашкрафт К.У.
ISBN 5-90131-10-10
Скачать (прямая ссылка):
35. DiSessa TG, Leitner M, Ті CC, et al.: The cardiovascular effects of dopamine in the severely asphyxiated neonate. J Pediatr 99:772 776, 1981.
36. Perkin RM, Levin DL, Webb R, et al.: Dobutamine: A hemodynamic evaluation in children with shock. J Pediatr 100:977— 983, 1982.
37. ParriUo JE: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227—242, 1990.
38. Tracey KJ, Lowry SF, Cerami A: Chacheciin: A hormone that triggers acute shock and chronic cachexia. J Infect Dis 157:413- 420, 1988.
39- Ned win GE, Svedersky LP, Bringman TS: Effect of interleukin-2, interferon-gamma and mitogens on the production of tumor necrosis factors alpha and beta. J Immuno! 135:2492— 2497, 1985.
40. Jupin C. Anderson S, Damais C, et al.: Toxic shock syndrome toxin I as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med 167:752—761, 1988.
41. Tracey KJ, Fong Y, Hesse DG, et al.: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacterae-mia. Nature 330:662—664, 1987.
42. Bcutler В Milsaark IW Cerami AC: Passive immunization against cachectin/iumor necrosis factor protects micc from the lethal effects of endotoxin. Science 229:869—871, 198L
43. Rosenstein M, Ettinghausen SE, Rosenberg SA: Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin-2. Immunol 137:1735, 1986.
44. Ognibene FP, Rosenberg SA, Lotze M. et al.: Interleukin-2 ad-
28 ФИЗИОЛОГИЯ РЕБЕНКА
ministration causcs reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. Chest 94:750, 1988.
45. Toyofuku T, Kubo K, Kohnyashi T, el al.: Effects of ONO-624C), a platelet activating factor antagonist, on endotoxin shock in unanesthetized sheep. Prostaglandins 31:271—281»
1986.
46. Danner R. Elin RJ. Hosline KM, el ні.: Endotoxin determinations in 100 patients with septic shock. Clin Res 36:453A, 1988.
47. Pryor RW, Hinshaw LB: Sepsis/septic shock in adutis and chil dren Pathol Immunopalhol Res 8:222 230. 1989.
48. Christensen RD, Harper ТЕ. Rothstein C: Granulocyte-macro-
phage progenitor cell (CFU-GM) in term and preterm neonates. J Pediatr 109:1042 1051. 1986.
49. Hill HR: Biochemical, structural and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 22:375—382, 1987.
50* Miller M: Chemotactic function in the human neonate: Humoral and cellular aspects. Pediatr Res 5:487 492, 1971.
51. Miller MF: Phagocytosis in the newborn: Humoral and cellular factors. J Pediatr 75:255—259, 1969.
52. Forman ML, Stiehm ER: Impaired opsonic activity but normal phagocytosis in Iow-birth-weight' Fhfams. N Engl J Med 281:926—931, 1969.
53. Cates KL, Rowe JC, Ballow M: The premature infant as a compromised host. C'urr Probl Pediatr 13:1 63, 1983.
54. Baskhurst AP, Morito T, Williams RC: Studies of human cord blood and adult lymphocyte interactions with in vitro immunoglobulin production. J Clin Invest 64:990—995, 1979.
55. Nagaoki T, Mitawaki T, Ciorbaru R. et al.: Maturation of В cell
differentia lion ability and T cell regulatory function during child growth assessed in a Nocardia water-soluble mitogen-drive system. J Immunol 126:2015 2019, 1981.
56. Anderson DC. Hughes BJ. Edwards MS, el al.: Impaired chemo-laxigenesis by type III group В streptococci in neonatal sera: Rclntionship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement. Pediatr Res 17:496—502. 1983.
57. Slossel TP, Alper CH, Rosen F: Opsonic activity in the newborn: Role of properdin. Pediatrics 52:134 137, 1973.
58. Cerdes JS. Yoder MC, Douglas SD, et al.: Decreased plasma fihronectin in neonatal sepsis. Pediatrics 72:877—88 L 1983.
59. Cairo MS, Sender L, Worcester C, et al.: A prospective randomized trial demonstrating the importance of bone marrow reserves and the advantage of PMN transfusion vs. intravenous gammaglobulin or supportive care in neonatal sepsis: Preliminary observations and expansion of previous study population. Abstracted. Pediatr Res 23:471 A. 1988.
60. Chirico G, Rondini G, Plebani A. el al.: Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. J Pediatr 110:437—442, 1987.
61. Clark SC, Kamen R: The human hematopoietic colony-stimula-ting factors. Science 236:1229—1237, 1987.
62. Sieff CA: Hematopoietic growth factors. J Clin Invest 79:1549.
1987.
63- Cairo MS. Van de Ven C. Toy C, et al.: Lymphokines: Enhancement by granulocyte-inacrophage and granulocyte colonystimu-lating factors of neonatal myeloid kinetics and functional activation of polymorphonuclear leukocytes. Rev Infect Dis I2(suppl) 4:S492—497, 1990.
Глава 2
ЭНТЕРАЛЬНОЕ И ПАРЕНТЕРАЛЬНОЕ ПИТАНИЕ
Интерес к вопросам питания хирургических больных стимулировался r последние два десятилетия достижениями в области энтеральною и парентерального питания. Наиболее значительной вехой на этом пути, несомненно, было введение Dudrick и его коллегами в 1968 г. парентерального питания в клиническую практику, что заставило врачей обратить внимание на особенности^ течения заболеваний, снизанные с питанием. ‘ * Вопросы потребностей в питании продолжают постоянно пересматриваться до настоящего времени по мере разработки проблем лечения различных видов патологии.
